249 related articles for article (PubMed ID: 12239311)
1. Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.
Boot HJ; ter Huurne AA; Hoekman AJ; Pol JM; Gielkens AL; Peeters BP
J Virol; 2002 Oct; 76(20):10346-55. PubMed ID: 12239311
[TBL] [Abstract][Full Text] [Related]
2. Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics.
Gao L; Qi X; Li K; Gao H; Gao Y; Qin L; Wang Y; Wang X
Vaccine; 2011 Jul; 29(33):5550-7. PubMed ID: 21658423
[TBL] [Abstract][Full Text] [Related]
3. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
[TBL] [Abstract][Full Text] [Related]
4. Novel variants of infectious bursal disease virus can severely damage the bursa of fabricius of immunized chickens.
Fan L; Wu T; Wang Y; Hussain A; Jiang N; Gao L; Li K; Gao Y; Liu C; Cui H; Pan Q; Zhang Y; Wang X; Qi X
Vet Microbiol; 2020 Jan; 240():108507. PubMed ID: 31902511
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of intermediate and intermediate plus infectious bursal disease virus (IBDV) vaccines against very virulent IBDV in commercial broilers.
Rautenschlein S; Kraemer Ch; Vanmarcke J; Montiel E
Avian Dis; 2005 Jun; 49(2):231-7. PubMed ID: 16094828
[TBL] [Abstract][Full Text] [Related]
6. Rescue of infectious bursal disease virus from mosaic full-length clones composed of serotype I and II cDNA.
Boot HJ; ter Huurne AA; Vastenhouw SA; Kant A; Peeters BP; Gielkens AL
Arch Virol; 2001 Oct; 146(10):1991-2007. PubMed ID: 11722019
[TBL] [Abstract][Full Text] [Related]
7. Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype.
Boot HJ; ter Huurne AA; Hoekman AJ; Peeters BP; Gielkens AL
J Virol; 2000 Aug; 74(15):6701-11. PubMed ID: 10888607
[TBL] [Abstract][Full Text] [Related]
8. Identification of a European interserotypic reassortant strain of infectious bursal disease virus.
Soubies SM; Courtillon C; Briand FX; Queguiner-Leroux M; Courtois D; Amelot M; Grousson K; Morillon P; Herin JB; Eterradossi N
Avian Pathol; 2017 Feb; 46(1):19-27. PubMed ID: 27400223
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Chicken Splenic-Derived Dendritic Cells Following Vaccine and Very Virulent Strains of Infectious Bursal Disease Virus Infection.
Yasmin AR; Yeap SK; Hair-Bejo M; Omar AR
Avian Dis; 2016 Dec; 60(4):739-751. PubMed ID: 27902915
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen.
Chen TH; Chen TH; Hu CC; Liao JT; Lee CW; Liao JW; Lin MY; Liu HJ; Wang MY; Lin NS; Hsu YH
Virus Res; 2012 Jun; 166(1-2):109-15. PubMed ID: 22406128
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
[TBL] [Abstract][Full Text] [Related]
13. Differences in genetic background influence the induction of innate and acquired immune responses in chickens depending on the virulence of the infecting infectious bursal disease virus (IBDV) strain.
Aricibasi M; Jung A; Heller ED; Rautenschlein S
Vet Immunol Immunopathol; 2010 May; 135(1-2):79-92. PubMed ID: 20005576
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunopathogenesis of mild, intermediate, and virulent strains of classic infectious bursal disease virus.
Rautenschlein S; Yeh HY; Sharma JM
Avian Dis; 2003; 47(1):66-78. PubMed ID: 12713160
[TBL] [Abstract][Full Text] [Related]
15. Infectious bursal disease virus in Algeria: Detection of highly pathogenic reassortant viruses.
Abed M; Soubies S; Courtillon C; Briand FX; Allée C; Amelot M; De Boisseson C; Lucas P; Blanchard Y; Belahouel A; Kara R; Essalhi A; Temim S; Khelef D; Eterradossi N
Infect Genet Evol; 2018 Jun; 60():48-57. PubMed ID: 29409800
[TBL] [Abstract][Full Text] [Related]
16. Rapid Generation of Attenuated Infectious Bursal Disease Virus from Dual-Promoter Plasmids by Reduction of Viral Ribonucleoprotein Activity.
Yang H; Wang Y; Ye C
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915284
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and molecular characterization of recent infectious bursal disease virus isolates in China.
Liu J; Zhou J; Kwang J
Virus Genes; 2002 Mar; 24(2):135-47. PubMed ID: 12018704
[TBL] [Abstract][Full Text] [Related]
18. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
[TBL] [Abstract][Full Text] [Related]
19. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
Huang Z; Elankumaran S; Yunus AS; Samal SK
J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain.
Perozo F; Villegas AP; Fernandez R; Cruz J; Pritchard N
Avian Dis; 2009 Dec; 53(4):624-8. PubMed ID: 20095167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
